Table 1.

Schedule of study visits and assessments of the eRadaR study

	Baseline	Hospital stay*		Discharge	90 days FU
Visits	V1 (Day 0)	V2 and 3 (Days 7, 14)		V4	V5 (Day 90)
Informed consent	X
Eligibility criteria	X
Demographic data:	X				X
(A) CCI	X
(B) RAI-C score
Ada diagnosis list	X
ICD-10 diagnoses	X			X	X
Symptoms	X
Diagnostics†		X		X
Therapy and OPS-code		X		X
Rate of consultations				X
Complications (CCI)		X		X	X
Length of hospital stay				X
Overall survival					X

(A) Routine blood samples (C reactive protein, white cell count, haemoglobin, platelets, sodium, potassium, creatinine, albumin, bilirubin, International normalized ratio (INR) (B) instrumental diagnostics (ultrasound, chest/abdominal CT/MRI, ECG, endoscopy).

*Visit 2 or 3 is left out, if the patient is discharged before.

†Diagnostics include.

CCI, Comprehensive Complication Index; FU, follow-up; ICD, International Classification of Diseases; OPS, operations and procedures; RAI-C, Risk Analysis C score; V, visit.